Bg pattern

DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Dipotassium phosphate 1M Fresenius Kabi 174.2 mg/ml concentrate for solution for infusion

Dipotassium phosphate

Read all of this leaflet carefully before you start using this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What Dipotassium phosphate 1M Fresenius Kabi is and what it is used for
  2. What you need to know before you use Dipotassium phosphate 1M Fresenius Kabi
  3. How to use Dipotassium phosphate 1M Fresenius Kabi
  4. Possible side effects
  5. Storage of Dipotassium phosphate 1M Fresenius Kabi
  6. Contents of the pack and other information

1. What Dipotassium phosphate 1M Fresenius Kabi is and what it is used for

Dipotassium phosphate 1M Fresenius Kabi is a medicine that belongs to a group called electrolyte solutions.

It is used for the replacement of phosphates and potassium in all clinical situations where it is necessary to maintain adequate phosphate and potassium concentrations in the blood:

  • Prevention and treatment of hypophosphatemia in patients under parenteral nutrition and/or in patients in intensive care units.
  • Diabetic ketoacidosis as a source of potassium.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Dipotassium phosphate 1M Fresenius Kabi

Do not useDipotassium phosphate 1M Fresenius Kabi

  • if you are allergic (hypersensitive) to dipotassium phosphate or any of the other components of Dipotassium phosphate 1M Fresenius Kabi.
  • if you have severe kidney disease.
  • if you have been detected with high levels of phosphate or potassium in the blood.
  • if you have episodes of kidney stones of ammonium and magnesium phosphates.
  • if you have kidney infections caused by microorganisms that hydrolyze urea.

Warnings and precautions

Before starting treatment with Dipotassium phosphate 1M Fresenius Kabi, your doctor should take special precautions and assess the administration or not of this medicine:

  • if you have previously had high levels of phosphates.
  • if you have previously had high levels of potassium.
  • if you have previously had low levels of calcium.

It is recommended, for all of the above, to monitor renal function, frequent ECGs, and periodic determinations of calcium, phosphorus, potassium, and sodium in the blood.

It should be ensured that the indicated doses are not exceeded, as phosphate poisoning and hyperkalemia (high levels of phosphate and potassium in the blood) may occur.

The intravenous perfusion of phosphates in large quantities can lead to hypocalcemia (low levels of calcium in the blood).

In chronic administration, fluid retention may occur.

Use of other medicines

Tell your doctor or pharmacist if you are using or have recently used other medicines, including those obtained without a prescription.

The parenteral use of dipotassium phosphate is not recommended together with digitalis glycosides, in digitalized patients, with severe or complete heart block, due to possible hyperkalemia (high levels of potassium in the blood).

If dipotassium phosphate is added to patients stabilized on salicylate treatments, it may produce an elevation of plasma levels of these to toxic concentrations, since the acidification of the urine by phosphates reduces the excretion of salicylates.

The concomitant administration of dipotassium phosphate and non-steroidal anti-inflammatory drugs, captopril, cyclosporine, diuretics that spare potassium, enalapril, heparin used chronically, lisinopril, low-sodium milk, salt substitutes, or other medicines that contain potassium may increase potassium levels in the blood, especially in patients with renal dysfunction.

Use ofDipotassium phosphate 1M Fresenius Kabiwith food and drinks

No interaction with food and drinks is known.

Pregnancy and lactation

Consult your doctor or pharmacist before using any medicine.

Driving and using machines

Dipotassium phosphate 1M Fresenius Kabi does not affect the ability to drive or use machines.

3. How to use Dipotassium phosphate 1M Fresenius Kabi

Follow exactly the administration instructions of Dipotassium phosphate 1M Fresenius Kabi indicated by your doctor. Consult your doctor or pharmacist if you have doubts.

Dipotassium phosphate 1M Fresenius Kabi will always be administered under the direct supervision of your doctor, who will closely monitor the administered dose.

Dipotassium phosphate 1M Fresenius Kabi is administered by slow injection into a vein (intravenous perfusion). The speed and amount administered will depend on your needs and the disorder to be treated, taking into account the recommended maximum daily dose.

Your doctor will decide what dose to administer to you.

Use in children

The normal dose in children is 2-3 mEq/kg/day.

If you use moreDipotassium phosphate 1M Fresenius Kabithan you should

If you receive more Dipotassium phosphate 1M Fresenius Kabi than you should, your phosphate and potassium levels in the blood may rise, as well as reduce your calcium levels in the blood.

Your doctor must ensure that you receive the correct amount of Dipotassium phosphate 1M Fresenius Kabi. In case the dose is too high for you, your doctor will immediately stop its administration and administer appropriate treatment.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Dipotassium phosphate 1M Fresenius Kabi can cause side effects, although not everybody gets them.

Side effects are associated with an excessive dose of the medicine that can produce high levels of potassium in the blood, low levels of calcium in the blood, and phosphate poisoning (hypocalcemic tetany, with convulsions, cramps, numbness, tingling, tremors, and difficulty breathing).

High levels of potassium in the blood are manifested with confusion, fatigue or weakness, cardiac arrhythmia, bradycardia, inexplicable anxiety, weakness or heaviness of legs.

If you think any of the side effects you are suffering from is serious, or if you notice any side effect not mentioned in this leaflet, tell your doctor or pharmacist.

If you experience any type of side effect, talk to your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Dipotassium phosphate 1M Fresenius Kabi

No special storage conditions are required. Keep in the original packaging to protect from light.

Keep out of the sight and reach of children.

Do not use Dipotassium phosphate 1M Fresenius Kabi after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.

Do not use Dipotassium phosphate 1M Fresenius Kabi if you notice that the solution is not transparent, free of particles, or the packaging is damaged.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Contents of the pack and other information

Composition ofDipotassium phosphate 1M Fresenius Kabi

  • The active principle is: dipotassium phosphate. Each ml of solution contains 174.2 mg of dipotassium phosphate (electrolytes: K+ 2 mmol, PO4H2- 1 mmol).
  • The other components are: water for injectable preparations.

Appearance of the product and contents of the pack

Dipotassium phosphate 1M Fresenius Kabi is an intravenous perfusion solution, transparent, colorless, and without visible particles, contained in 10 ml glass ampoules.

The pack contains 1 ampoule, 10 ampoules, or 100 ampoules (clinical packaging).

Marketing authorization holder and manufacturer

Marketing authorization holder

Fresenius Kabi España S.A.U.

Marina 16-18,

08005 – Barcelona

Manufacturer

Labesfal - Laboratórios Almiro, S.A.

Zona Industrial do Lagedo

3465-157 Santiago de Besteiros

Portugal

or

Laboratoire Renaudin

  • A. Errobi

F-64250 Itxassou

This leaflet was approved in: August 2020

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

-----------------------------------------------------------------------------------------------------------------------

This information is intended only for doctors or healthcare professionals:

The administration of Dipotassium phosphate 1M Fresenius Kabi is by intravenous perfusion. The product requires dilution before use, with at least an equal amount of diluent.

The product can be diluted with 5% and 10% glucose solutions, 0.9% and 0.45% sodium chloride, and 1/6 M sodium lactate. It is also compatible for 24 hours at 22°C with parenteral nutrition solutions.

Dipotassium phosphate should not be dissolved with Ringer's, Ringer's Lactate, and 10% Dextrose plus 0.9% Sodium Chloride solutions.

The dipotassium phosphate solution should not be added with dobutamine, as precipitates are formed.

Dipotassium phosphate is compatible with the addition of magnesium sulfate, metoclopramide, verapamil, cefalotin, and ceftazidime; in parallel (Y perfusion), it is compatible with: ciprofloxacin, diltiazem, enalapril, esmolol, famotidine, labetalol, vinorelbine, and zidovudine.

Use only if the solution is clear.

The disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations.

Online doctors for DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION

Discuss questions about DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (766)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50

Frequently Asked Questions

Is a prescription required for DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION?
DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION?
The active ingredient in DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION is potassium phosphate, incl. combinations with other potassium salts. This information helps identify medicines with the same composition but different brand names.
Who manufactures DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION?
DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION is manufactured by Fresenius Kabi España, S.A.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DIPOTASSIUM PHOSPHATE 1M FRESENIUS KABI 174.2 mg/mL INJECTABLE SOLUTION?
Other medicines with the same active substance (potassium phosphate, incl. combinations with other potassium salts) include POTASSIUM ACETATE B.BRAUN 1 mEq/ml CONCENTRATE FOR INFUSION SOLUTION, SODIUM BICARBONATE 1/6 M MEIN SOLUTION FOR INFUSION, SODIUM BICARBONATE 1M GRIFOLS INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media